Current therapeutic approaches to haemostasis correction in covid-19: a systematic review
Кубанский научный медицинский вестник, 2021 Background. The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has swept across countries worldwide. Despite an unprecedented volume of research, few drug therapies have been proved effective.
V. N. Antonov +3 more
doaj +1 more source
Management of Allergic Diseases During COVID-19 Outbreak [PDF]
, 2021 Coronavirus infections; Rhinitis, Allergic; Drug hypersensitivityInfecciones por coronavirus; Rinitis alérgica; Hipersensibilidad medicamentosaInfeccions per coronavirus; Rinitis al·lèrgica; Hipersensibilitat medicamentosaPurpose of review: The ...
Alobid, Isam +2 more
core +1 more source
Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics
Pharmaceutics, 2021 An increasing number of clinical studies worldwide are investigating the repurposing of antiviral, immune-modulatory, and anti-inflammatory agents to face the coronavirus disease-19 (COVID-19) pandemic.
Matteo Puccetti +3 more
doaj +1 more source
A REVIEW ON THE ANTIPARASITIC DRUG IVERMECTIN FOR VARIOUS VIRAL INFECTIONS AND POSSIBILITIES OF USING IT FOR NOVEL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2: NEW HOPE TO TREAT CORONAVIRUS DISEASE-2019 [PDF]
, 2020 The novel coronavirus infection has spread all over the world. With no specific drug or vaccine, the process of “drug repurposing” becomes a feasible solution.
JABEEN, SHAYESTHA +2 more
core +1 more source
From omics to AI—mapping the pathogenic pathways in type 2 diabetes
FEBS Letters, EarlyView.Integrating multi‐omics data with AI‐based modelling (unsupervised and supervised machine learning) identify optimal patient clusters, informing AI‐driven accurate risk stratification. Digital twins simulate individual trajectories in real time, guiding precision medicine by matching patients to targeted therapies.
Siobhán O'Sullivan +2 more
wiley +1 more source
Medicine in Drug Discovery, 2020 The COVID-19 pandemic, after it was reported in December 2019, is a highly contagious and now spreading to over 190 countries, causing a severe public health burden.
Jiayu Liao, George Way, Vipul Madahar
doaj
Repurposing the drug, ivermectin, in COVID-19: toxicological points of view
European Journal of Medical Research, 2022 The global COVID-19 pandemic has affected the world’s population by causing changes in behavior, such as social distancing, masking, restricting people’s movement, and evaluating existing medication as potential therapies.
Farshad M. Shirazi +5 more
doaj +1 more source
Biomedicines, 2022 Sex differences identified in the COVID-19 pandemic are necessary to study. It is essential to investigate the efficacy of the drugs in clinical trials for the treatment of COVID-19, and to analyse the sex-related beneficial and adverse effects.
Donatas Stakišaitis +11 more
doaj +1 more source
CHLOROQUINE AND HYDROXYCHLOROQUINE: A MAJOR BREAKTHROUGH FOR COVID-19 [PDF]
, 2020 Coronavirus pandemic or COVID-19 is a global public health emergency at this period. Presently, no pharmacological treatment is known to treat this condition.
KUMAR, INDER, VERMA, KRITIKA
core +1 more source
Sex differences in the utilization of drugs for COVID-19 treatment among elderly residents in a sample of Italian nursing homes [PDF]
, 2022 PurposeTo describe the use of hydroxychloroquine (HCQ), azithromycin (AZI) and low-molecular-weight-heparins (LMWH) by sex among elderly residents in nursing homes (NHs) of Tuscany region (Italy) during the first pandemic peak.MethodsA population-based ...
Collini, Francesca +11 more
core +2 more sources